secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001178913-26-000244
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward schedules March 12 meeting to vote on Oratech acquisition from Oramed; board to expand to 8
--------------------------------------------------------------------------------

- EGM on March 12, 2026 to approve issuance of shares to Oramed as consideration for acquiring all of Oratech.
- Upon closing, board to consist of 8 members: 3 from Lifeward, 3 from Oramed, and 2 external directors.
- Oramed would hold at least 45% (potentially >49.99%) of voting power, triggering change-of-control rules.
- Other proposals: election of external directors, increase in 2025 incentive plan shares, CEO equity grant, auditor reappointment.
- Definitive proxy statement expected to be filed on or about February 9, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326000244/0001178913-26-000244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326000244/zk2634263.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-000244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer